Blood vessels in the central nervous system (CNS) are controlled by neuronal activity. For example, widespread vessel constriction (vessel tone) is induced by brainstem neurons that release the monoamines serotonin and noradrenaline, and local vessel dilation is induced by glutamatergic neuron activity. Here we examined how vessel tone adapts to the loss of neuron-derived monoamines after spinal cord injury (SCI) in rats. We find that, months after the imposition of SCI, the spinal cord below the site of injury is in a chronic state of hypoxia owing to paradoxical excess activity of monoamine receptors (5-HT 1 ) on pericytes, despite the absence of monoamines. This monoamine-receptor activity causes pericytes to locally constrict capillaries, which reduces blood flow to ischemic levels. Receptor activation in the absence of monoamines results from the production of trace amines (such as tryptamine) by pericytes that ectopically express the enzyme aromatic l-amino acid decarboxylase (AADC), which synthesizes trace amines directly from dietary amino acids (such as tryptophan). Inhibition of monoamine receptors or of AADC, or even an increase in inhaled oxygen, produces substantial relief from hypoxia and improves motoneuron and locomotor function after SCI.
The central nervous system (CNS) is highly susceptible to damage when its blood supply is compromised [1] [2] [3] . Accordingly, the CNS has numerous control systems to ensure adequate blood supply, including (i) neurovascular coupling, whereby neuronal activity locally dilates blood vessels to increase blood flow through glutamate and nitric oxide (NO) signaling; (ii) metabolic coupling, whereby energy systems (including O 2 ) regulate neuronal activity and vessel diameter; and (iii) basal vascular tone, whereby CNS-derived neuromodulators, such as serotonin (5-HT), noradrenaline (NA) and dopamine, along with myogenic tone, produce widespread vasoconstriction. This effectively conserves blood for locally active areas dilated by neurovascular coupling [4] [5] [6] [7] . The latter basal-tone phenomenon is analogous to the sympathetic control system in the periphery, in which NA causes widespread vessel tone 8, 9 ; however, in the CNS, neurons in the brainstem provide most of the NA and 5-HT, except for sympathetic innervation of large pial arteries [10] [11] [12] [13] [14] .
In the setting of severe SCI, vessels and neurons caudal to the injury survive, but they lose monoamine innervation that normally arises primarily from brainstem neurons 15 . Although vessels directly damaged by SCI undergo well-documented plasticity at the injury epicenter [16] [17] [18] , including angiogenesis 19 , little is known about the uninjured vessels caudal to the site of the SCI, especially long after injury 2 . Considering that uninjured spinal neurons undergo remarkable adaptations that compensate for the loss of supraspinal monoamine innervation after SCI 15, 20, 21 , we investigated whether vessels undergo similar adaptations. Normally, 5-HT and other monoamines in the spinal cord are synthesized exclusively in brainstem-derived axons through enzymatic pathways, such as the conversion of tryptophan to 5-HTP and then to 5-HT by the actions of tryptophan hydroxylase (TPH) and AADC, respectively 14 . After SCI, there is a loss of axons in which these enzymes are expressed, and thus enzyme levels are dramatically reduced, with one notable exception: spinal capillaries-which normally only weakly express AADC and lack other relevant enzymes, such as TPH-markedly upregulate AADC expression caudal to the injury 22, 23 .
Although AADC activity alone is not sufficient for endogenous synthesis of 5-HT (and indeed, vessels lack 5-HT after SCI 14, 23, 24 ), AADC can directly synthesize trace amines (TAs; Supplementary  Fig. 1) , such as tryptamine and tyramine, from amino acids such as tryptophan and tyrosine. In general, the endogenous functions of TAs have remained largely elusive, especially in the spinal cord 14, [25] [26] [27] . TAs are not packaged or released in vesicles, they lack a high affinity transporter and they are, accordingly, rapidly metabolized by monoamine oxidase (MAO), leaving only trace (nanomolar) quantities 23, 25, 26 . However, when AADC is present at high levels, as within capillaries after SCI, TAs are likely to reach the high micromolar concentrations of their precursor amino acids circulating in the blood 28, 29 because amino acids are readily transported into all cells 30 . At these micromolar concentrations, TAs activate 5-HT 1 receptors (tryptamine), α 2 adrenergic receptors (tyramine and phenylethylamine) 31, 32 and specialized TA-associated receptors (TAARs) 33 , and they have known effects on the heart and mesentery vasculature 34, 35 . Thus, we hypothesized that TAs synthesized by AADC locally in capillaries might directly regulate vessel tone after SCI, replacing lost monoamine innervation.
Classically, CNS blood flow is thought to be controlled by smooth muscle cells (SMCs) of arterioles that constrict in response to vasoactive substances, including centrally derived 5-HT and NA acting on 5-HT 1 and α 2 adrenergic receptors 4, [10] [11] [12] 14, [36] [37] [38] [39] [40] [41] [42] , through similar mechanisms that occur in the periphery 9, 42 . Arterioles branch to form small capillaries that lack SMCs but are associated with sparsely spaced pericytes that wrap around CNS capillaries 41 (Fig. 1) . Although pericytes have diverse functions, including contributing to scar formation after SCI 43 , many pericytes are contractile, containing smooth-muscle α-actin (α-SMA) and contracting in response to monoamines 4, 6, 41, 44 . Indeed, pericytes have recently been shown to have a major role in both the control of normal CNS blood flow and the response to ischemic stroke 6, 7, 14, 37, [44] [45] [46] . Coincidentally, we noticed that when AADC is upregulated in capillaries after SCI, it is most intensely expressed in pericytes 23 . Thus, we explore here whether pericytes, by synthesizing TAs that replace lost monoamines, have a special role in the regulation of capillary tone and blood flow after SCI.
RESULTS
Endogenously produced trace amines (TAs) constrict capillaries at pericytes after SCI In the spinal cords of healthy normal and injured rats, immunolabeling with the pericyte marker NG2 revealed pericytes at points spaced approximately every 50 µm along capillaries (Fig. 1b) , as previously described elsewhere in the brain 6 . These pericytes have a characteristic hemispherical soma, unlike astrocytes, endothelial cells or SMCs (Fig. 1a,b and Supplementary Fig. 2) , which enabled us to identify them morphologically while imaging whole spinal cords maintained in vitro, using live-tissue differential-interference microscopy (DIC; Fig. 1c ,d) 6 . In spinal cords caudal to a chronic spinal transection, the application of physiological concentrations of tryptophan, tyrosine or phenylalanine (10-100 µM) 28, 29 induced tonic local constrictions of capillaries adjacent to pericytes ( Fig. 1d,i ; in 72%, 66% and 78% of pericytes, respectively), consistent with the idea that increased expression of AADC in capillaries caudal to a SCI 23 leads to the production of TAs. Capillary regions without pericytes lacked constrictions ( Fig. 1d) , in keeping with the concept that pericytes are responsible for the vasoconstrictions, as previously demonstrated in the uninjured CNS 6, 45 . The tryptophan-induced constrictions produced changes in vessel morphology and cord opacity and widespread displacement of red blood cells (RBCs; Supplementary Fig. 3 and Supplementary Video 1). In summary, after SCI, the application of tryptophan led to a 25% decrease in the diameter of the capillary at points adjacent to pericytes, halving the local cross-sectional area ( Fig. 1i) , which should severely impair blood flow.
The AADC inhibitor NSD1015 eliminated tryptophan-induced vasoconstriction ( Fig. 1e,i) , consistent with the conclusion that AADC-mediated conversion of tryptophan to tryptamine is responsible for inducing vasoconstriction. Indeed, exogenously applied tryptamine induced vasoconstrictions at 70% of pericyte contact points, mimicking the effect of tryptophan, and this tryptamine-induced vasoconstriction was resistant to NSD1015 ( Fig. 1f,i) . NSD1015 alone had no effect on vessel diameter ( Fig. 1i) , which indicates that there is inadequate endogenous free tryptophan in vitro for AADC action (unlike conditions in vivo, as described below). Tryptophan did not constrict arterioles after SCI ( Fig. 1i) , which rules out the possibility that endogenously produced tryptamine can constrict these vessels. Tryptophan had no effect on capillaries or arterioles in spinal cords from uninjured normal rats ( Fig. 1h,i) , consistent with the relative lack of vessel-associated AADC in uninjured spinal cords (as described in 'Mechanisms of pericyte action after SCI').
Trace amines activate 5-HT 1B and a 2 adrenergic receptors to constrict capillaries We next tested whether TAs replace the function of monomines lost as a result of injury by activating monoamine receptors. Indeed, tryptamine-and tryptophan-induced capillary vasoconstriction in chronic spinal rats were blocked by the selective 5-HT 1B/D receptor antagonist GR127935 ( Fig. 1g,i) and were mimicked by the 5-HT 1B/D receptor agonist zolmitriptan ( Fig. 1i) , at doses consistent with zolmitriptan's moderate affinity for 5-HT 1B receptors, and not its high affinity for 5-HT 1D receptors 20 . Tyrosine-induced vasoconstriction (through AADC-mediated synthesis of tyramine) was blocked by the α 2 -receptor antagonist RX821002 ( Fig. 1i) . 5-HTP, which is converted to 5-HT by AADC, had mixed effects on capillaries, constricting them at low doses-consistent with action at the 5-HT 1B receptor-but dilating them at higher doses ( Fig. 1i and Supplementary Fig. 4 ). In spinal cords from uninjured normal rats, 5-HT generally induced capillary constrictions at pericytes ( Fig. 1i) .
Mechanisms of pericyte action after SCI
In the spinal cord from uninjured normal rats (or in the spinal cord rostral to the site of injury after SCI), AADC immunolabeling was predominantly in axons (descending monoamine fibers), whereas it was absent (or only weakly expressed) in most vessels, as previously detailed 23 (Supplementary Fig. 5a ). By contrast, caudal to a spinal cord transection, AADC immunolabeling was highly upregulated in vessels and not generally present in axon tracts 23 (Supplementary Fig. 5b and Fig. 2 ). Double immunolabeling with the pericyte markers CD13 or NG2 revealed that this vessel AADC expression was entirely colocalized with pericytes on capillaries and had more intense expression near the pericyte membrane, as compared to that in the cytoplasmespecially at points adjacent to the vessel wall (forming a flat disc; Fig. 2a,c,d and Supplementary Figs. 5-7). By contrast, AADC was not coexpressed with an endothelial cell marker ( Supplementary  Fig. 6 ), indicating a lack of endothelial AADC. AADC and its enzymatic products were present in capillary pericytes throughout the white and gray matter, including the dorsal horn and dorsal columns ( Fig. 2a and Supplementary Figs. 5 and 8) . AADC immunolabeling was not seen on arteries or arterioles ( Fig. 2a) .
Immunolabeling for tryptamine (or other AADC products) revealed that this TA was endogenously expressed in capillaries caudal to the site of injury after an SCI, with dense punctate expression in the pericyte soma ( Fig. 2b and Supplementary Figs. 7-9 ). Furthermore, this tryptamine staining was eliminated by pretreatment of the rats with NSD1015 ( Supplementary Fig. 7d ). These results are consistent with the concept that pericyte AADC produces tryptamine from endogenous tryptophan ( Fig. 2e) . By contrast, tryptamine immunolabeling was largely absent from most capillaries rostral to the site of injury or in uninjured spinal cords ( Supplementary Fig. 7) . Immunolabeling for 5-HT 1B receptors revealed that these receptors were densely expressed on pericytes ( Fig. 2g and Supplementary Fig. 10) , where they could be readily activated by tryptamine synthesized locally by the pericyte itself ( Fig. 2e) .
Immunolabeling for 5-HT confirmed previous findings that 5-HT is completely absent caudal to the spinal cord transection ( Fig. 2f and Supplementary Fig. 8b ) 23 . However, pretreatment of these chronic spinal rats by injection of the 5-HT precursor 5-HTP led to pronounced 5-HT immunolabeling in the microvasculature (Fig. 2c,d and Supplementary Fig. 8a ). This 5-HT staining is eliminated by the injection of an AADC blocker 23 , revealing that this vessel 5-HT is entirely produced by AADC and thus 5-HT is a useful surrogate marker of AADC's ability to produce amines after SCI. This AADC product (5-HT staining) colocalized with pericyte AADC staining ( Fig. 2c,d , and NG2 pericyte labeling) and accumulated densely in the cytoplasm of the pericyte soma, adjacent to patches of dense AADC labeling ( Fig. 2d and Supplementary Fig. 9 ), similar to tryptamine's localization. The mRNA expression of the pericyte marker CD13 was increased 45% caudal to the SCI, and the expression of other pericyte signaling molecules was also altered, suggesting a proliferation of pericytes after SCI ( Supplementary. Fig. 11 ) 47 .
Endogenous trace amines induce hypoxia after SCI
Considering that physiological concentrations of tryptophan constrict capillaries through endogenous production of TAs, we next examined blood flow in vivo. In the spinal cord below a chronic transection injury, the vasculature perfusion rate was half that in the cord above the injury or in normal spinal cords, as quantified by the time taken to fill all vessels with the vital dye methylene blue after intracardial injection ( Fig. 3a,b) . Furthermore, when we injected a fluorescent dextran into the blood, two-photon fluorescence microscopy revealed that the flow rates in spinal capillaries were abnormally low after SCI a r t i c l e s 7 3 6 VOLUME 23 | NUMBER 6 | JUNE 2017 nature medicine ( Fig. 3c) , as compared to those in the uninjured CNS 48 . Blocking TA production with an AADC blocker ( Fig. 3c) or TA action with a 5-HT 1B receptor antagonist ( Fig. 3b ) restored blood flow to near normal rates (doubling flow), consistent with the concept that endogenous tryptophan acts through AADC to restrict capillary flow in vivo. In a control experiment, application of an NO donor to fully dilate vessels showed that the unconstricted vasculature had equal perfusion capacity in uninjured rats and rats with SCI ( Fig. 3b) .
We next measured tissue oxygenation (pO 2 ) in vivo. The spinal cord caudal to the site of injury was chronically hypoxic along its entire length (pO 2 << 20 mm Hg 49-51 ), with pO 2 values caudal to the injury less than half of those rostral to the injury or of the uninjured spinal cord ( Fig. 3d,e ). Treatments that dilate the capillaries-inhibition of AADC or blockade of 5-HT 1B or α 2 adrenergic receptors-restored pO 2 to normal levels caudal to the site of injury, but did not affect pO 2 rostral to the site of injury ( Fig. 3e,f) . Tryptophan application itself did not alter pO 2 , likely because endogenous tryptophan levels in the CNS and circulation (~50 µM) 28,29 are already well above the concentration that we found produces peak effects in the isolated spinal cord (10 µM; Fig. 1i ). A short period of hyperoxia (1 min), in which the concentration of inhaled O 2 was raised to 100% or 95% (with 5% CO 2 , to maintain breathing rate), rapidly increased arterial pO 2 from ~100 to ~400 mm Hg, and accordingly, increased spinal cord pO 2 to well above normal values ( Fig. 3e , blue bar), demonstrating that caudal blood flow is inadequate to supply normal oxygenation without an artificial increase in arterial oxygen levels. Unexpectedly, after this 1-min period of hyperoxic breathing, cord pO 2 caudal to the site of injury remained elevated for 20 min, whereas rostral to the injury, the cord pO 2 returned rapidly (within 1 min) to normal ( Fig. 3e) , as did breathing rate, exhaled CO 2 and arterial pO 2 (Online Methods). This prolonged elevation in cord pO 2 caudal to the site of injury is likely due to the effect of increased oxygenation on raising neural activity, which, in turn, triggers neurovascular coupling that dilates vessels and further increases oxygen and neural activity in a positive-feedback loop (especially in the hyperexcitable cord after SCI 15 ). Indeed, we observed prominent neurovascular coupling after SCI, caudal to the site of injury ( Supplementary Fig. 12 ). Transient breathing of 100% O 2 (1 min) likewise led to a prolonged (20 min total) elevation in pO 2 caudal to the site of injury, as did breathing air with increased CO 2 levels (10% CO 2 in air for 30 s, because CO 2 dilates vessels 1 ) or even in mildly hypoxic conditions (10% O 2 in air for 1 min) ( Supplementary Fig. 13 ).
Motor function is enhanced by blocking trace amine action and preventing hypoxia
To evaluate the functional effects of impaired blood flow and chronic hypoxia after SCI, we recorded electromyography (EMG) activity in the paralyzed tail muscles of the awake chronic spinal rat (sacral transection; Fig. 4 ) 15 . Treatments that dilated spinal capillaries-the receptor antagonists GR127935 or RX821002, or inhalation of 10% CO 2 -increased spontaneous EMG activity ( Fig. 4a-c,f) . Likewise, treatments that indirectly increase spinal cord blood flow by systemically augmenting blood pressure (peripherally acting dobutamine or vasopressin) also increased EMG activity ( Supplementary  Fig. 14) . Transient hyperoxic breathing (95% O 2 for 1 min) to increase spinal cord oxygenation by raising arterial pO 2 also increased spontaneous EMG activity, and effects lasted 20 min beyond the treatment period (Fig. 4d,f) , consistent with the cord-pO 2 measurements (Fig. 3e) . Each of these treatments also increased sensory-evoked EMG responses (long-lasting reflexes, LLRs; Fig. 4b-f ) and increased the incidence of rhythmic locomotor-like bursting (Fig. 4d , blue thin line; Supplementary Fig. 14) . Hyperoxia or hypercapnia produced similar increases in EMG when repeated at >60-min intervals.
To rule out direct actions of TAs on neurons, we also examined motor activity and sensory-evoked motor responses (LLRs) in the ventral roots of isolated spinal cords from chronic spinal rats. The spinal cords were maintained in vitro in oxygenated artificial cerebrospinal fluid (nACSF), in which vessels have no influence ( Supplementary  Fig. 15a,b) . Notably, in these isolated cords, motor activity (as measured by LLRs) was not altered by treatment with NSD1015, GR127935, RX821002 (Fig. 4c) or tryptophan ( Supplementary Fig. 15d,e ).
The lack of an effect of tryptophan indicates that TAs endogenously produced from tryptophan have no direct effect on neurons. Although exogenous application of high doses of TAs did increase the LLR amplitudes, this effect was mediated by a different receptor subtype (blocked by 5-HT 2C receptor antagonist) than the monoamine receptors that control capillaries ( Supplementary Fig. 15f,i) . Furthermore, transient alteration of the pO 2 of the ACSF in the in vitro preparation from normoxic to hyperoxic levels transiently altered motoneuron activity (LLRs; Fig. 4e,f) : an increase in pO 2 produced an increase in LLRs, consistent with a previous report 52 . However, this increase in LLRs did not outlast the O 2 application, in keeping with the concept that increased blood flow through neurovascular coupling mediates the sustained pO 2 and LLRs observed in vivo after O 2 breathing (Fig. 4e,f) .
Locomotor function after SCI is improved by treatments that improve capillary blood flow To evaluate locomotion after SCI, we studied rats with a thoracic SCI from either a severe contusion or a staggered-hemisection injury (Fig. 5) ; the latter type of injury transects most descending axons, including removing 5-HT 15, 53 (Supplementary Fig. 16 ). A month after these injuries, rats regained some voluntary hind-limb locomotor ability, although weight support was impaired, plantar-foot placement was poor and step timing was slow, in part because of leg-extensor spasms (Fig. 5b) . In the lumbar region caudal to the injury, pO 2 was hypoxic, significantly lower than levels rostral to the site of injury or in uninjured spinal cord ( Fig. 5f,g) . The dilation of capillaries induced by locally applied GR127935 or RX821002 restored pO 2 to near-normal levels (Fig. 5f,g) , with effects lasting as long as the drug was present (durations of 30-90 min were tested). Transient hyperoxic O 2 breathing (95%, 90 s) likewise restored normal pO 2 , and effects lasted 20 min ( Fig. 5f,g) , as seen in chronic spinal rats in Figure 3 . Intrathecal injection of GR127935 or NSD1015 to dilate capillaries, or transient O 2 breathing, significantly improved walking ability ( Fig. 5c-e ). These improvements in locomotion with GR127935 or oxygen breathing lasted 10-30 min, consistent with the pO 2 measurements and with the known washout time of intrathecal drug injections 15 . In keeping with the action of NSD1015 as an irreversible AADC inhibitor, NSD1015's actions lasted for at least 24 h, demonstrating sustained improvements in locomotor function with vessel dilation (Fig. 5e) .
DISCUSSION
Our results demonstrate several new concepts that fundamentally alter the understanding of spinal cord function and rehabilitation after SCI: (i) after SCI, pericytes play a major part in the regulation of capillary tone and blood flow in the spinal cord; (ii) SCI leads to a chronic state of excess capillary tone, poor blood flow and hypoxia; (iii) the monoamine receptors 5-HT 1B and α 2 regulate capillary tone in the absence of the monoamines 5-HT and NA in transected cords; (iv) AADC expressed in capillary pericytes synthesizes the TAs tryptamine and tyramine from physiological concentrations of dietary amino acids, and these TAs are responsible for monamine receptor activation, thereby replacing the action of brainstem-derived monoamines lost with SCI; and (v) antagonism of monoamine receptors, inhibition of AADC enzyme function or augmentation of inhaled O 2 or CO 2 after SCI produces lasting improvements in blood flow and cord oxygenation, which ultimately improves motor function, including locomotion. Notably, we found that chronic spinal cord hypoxia occurs with clinically relevant partial SCI (contusion injury), and that long-term improvement in locomotor function can Supplementary Fig. 15 ). LLR normalized to LLR before drugs, 100%. be achieved with interventions that dilate vessels (for example, AADC inhibitors). These results suggest that alleviation of chronic hypoxia is a promising approach to rehabilitation after SCI.
Our results also show that TAs produced endogenously from amino acids (through AADC) do not directly affect neuronal activity (see also ref. 27 ), but, instead, act only on vessels caudal to the site of injury. Whereas exogenously applied TAs can directly affect neuronal function through the 5-HT 2 and TAAR receptors 27 , TAs endogenously produced in vessels are likely metabolized by MAO before they can diffuse to neurons 23 . Furthermore, the treatments that we used to dilate capillaries after SCI-a selective 5-HT 1B antagonist (GR127935) and an AADC inhibitor-act primarily on pericytes rather than on neurons, given that they did not affect neuronal activity in isolated cords maintained in vitro. Additionally, GR127935 could not have directly affected locomotor or motoneuron function, because after severe SCI, there is little to no 5-HT present to activate locomotor-related 5-HT receptors; even if these receptors were somehow activated (by residual 5-HT in the contusion rats), the primary locomotor-related receptors include 5-HT 2A/C and 5-HT 1A receptors 53 , which are not antagonized by GR127935.
The concept that pericytes have a major role in the control of blood flow has only recently been described in the brain (cerebellum and retina) 6, 7, 44, 45 and has not been previously demonstrated in the spinal cord. Pericytes and SMCs can both regulate CNS blood flow, but controversy exists as to whether pericytes or SMCs have the primary role 54 , particularly because pericytes are highly diverse-many contain α-SMA, but others do not [43] [44] [45] [46] 54, 55 . Our results demonstrate that capillary pericytes can play a primary part in the regulation of blood flow, because treatment with tryptophan after SCI induces widespread constrictions of capillary pericytes, but not of arterioles, through the action of AADC expressed exclusively in pericytes and not expressed in arterioles, arteries or SMCs 14,23 Furthermore, blocking the action of pericyte AADC (with NSD1015) or of associated TAs on the 5-HT 1B receptor (with GR127935) markedly improves blood flow, oxygenation and motor function in vivo. Although arterioles with SMCs express monoamine receptors and respond to exogenously applied monoamines (5-HT and tryptamine) 11, 14, 36 , AADC products produced by pericytes likely do not diffuse sufficiently far to influence distant arterioles or neurons 23 .
The marked chronic hypoxia (pO 2 , ~10 mm Hg) that we observed in the cord far caudal of the site of injury was unexpected, especially in the case of partial injury (contusion injury), given that previous studies have focused on the acute stage of injury and the injury epicenter 2, 16, 19, 43 . In contrast to hypoxia caudal to the site of injury, the cord rostral to the injury is well oxygenated (28 mm Hg), similar to that reported for the uninjured spinal cord and brain [49] [50] [51] . On the basis of these observations, any treatment that increases systemic blood flow or arterial pO 2 , including exercise 53, 56 , should also increase cord oxygenation and indirectly modulate neuronal function 52 , which is consistent with our findings after manipulation of blood pressure and inhaled O 2 concentrations. Chronic spinal cord hypoxia is likely to contribute to long-term disabilities that slowly emerge after SCI, including metabolic plasticity 19 , chronic spinal cord inflammation 18, 47 , long-term deterioration and the loss of neurons 57 , as well as exhaustion during locomotor activity 58 . Increasing cord perfusion (and pO 2 ) may reduce these clinical problems, although the adverse effects of reactive oxidative species should be considered if oxygenation were to be abruptly increased 1 . Paradoxically, we found that transient hypoxic breathing produces a rebound increase in spinal pO 2 that lasts >20 min, which might help to explain why intermittent hypoxic breathing improves rehabilitation after SCI 59 .
Our finding that TAs control capillary tone arguably represents the first time that endogenous TAs have been shown to have a standalone spinal cord function, in the absence of classical monoamines. Previously, secondary functions have been ascribed to TAs in the CNS involving their modulation of monoamine function 25, 26 , including TAs modulating the dopamine transporter, to compensate for reductions in dopamine 33, 60 . The latter dopamine mechanism involves TAs that act on the same cell in which they are produced (the dopamine neuron). Similarly, our results suggest that TAs produced by AADC in pericytes act locally to induce constriction of the same pericyte. AADC is expressed densely in the pericyte, especially adjacent to the vessel wall, which allows for ready access to blood-borne tryptophan 30 to produce tryptamine; this in turn diffuses throughout the pericyte (filling the soma) and acts on the 5-HT 1B receptor on the pericyte itself to produce vasoconstriction ( Fig. 2e, schematic) . This probably requires tryptamine to leave the pericyte (through a transporter such as the organic cation transporter, OCT 27 ) to act extracellularly on 5-HT 1B receptors in the pericyte membrane, although we cannot rule out direct action of tryptamine on intracellular 5-HT 1B receptors 27 . After SCI, a few neurons also upregulate AADC expression 23, 24 , which may complement pericyte function in regulating vessel tone, given that these neurons contact vessels; these neurons may even arise from the proliferating pericytes 23 .
The remarkable adaptation of capillary pericytes to SCI is functionally similar to the adaptation of motoneurons to SCI: motoneurons become hyperactive owing to paradoxical monoamine-receptor activity, which ultimately leads to muscle spasms 15, 21 . However, the mechanisms underlying the effects of SCI on pericytes and motoneurons are different. Motoneurons upregulate isoforms of 5-HT 2C receptors that are constitutively active 15 , whereas pericytes upregulate AADC that produces TAs, which in turn leads to 5-HT 1B receptor activation.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS

Rat models of spinal cord injury.
All rat experiments were approved by the Health Sciences University of Alberta Animal Care and Use Committee. Most of the studies, except the locomotor-related studies, were performed using the sacral-transection injury model, in which the S2 sacral spinal cord was transected in adult female Sprague-Dawley rats at ~2 months of age, as described previously 15, 23 . Briefly, under general anesthetic (sodium pentobarbital, 58.5 mg/kg, and isoflurane) and sterile conditions, a laminectomy was performed on the L2 vertebrae to expose the S2 spinal cord. The dura was slit transversely, and 0.1-0.3 ml of xylocaine (1%) were applied topically. Using a surgical microscope, the spinal cord was transected by holding the pia with forceps and removing tissue using suction (using a 1-cc syringe that had been melted and pulled to a fine tip). Caution was taken to avoid damaging the anterior artery or posterior/dorsal vein, because the sacrocaudal spinal cord dies without this midline vasculature. The dura was closed with two 8-0 silk sutures, the muscle layers and skin were tightly sutured over the cord and the rat was allowed to recover. All experiments were performed 2-4 months after injury, when tail-muscle spasticity was fully developed and rats were considered to be in a chronic spinal state (chronic spinal rats) 15 . Nonspastic rats with inactive tails were excluded. Chronic spinal rats were compared to age-matched normal uninjured rats (rats were randomly assigned to these two groups).
Contusion and staggered-hemisection injury models were used for locomotion studies 15 . Under anesthesia with fentanyl (Hypnorm 120 µl/200 g; Janssen, Canada) and midazolam (0.75 mg/200 g; Sabex, Belgium), adult female Sprague-Dawley rats were injured at ~6 weeks of age. Rats received either a severe contused injury at spinal T8 vertebrae (impact force, 200 kDyn) or underwent a staggered hemisection. The latter rats were first hemisected on the right at the T10 spinal vertebrae (T10-T11 cord level). Then, 2 weeks later, rats received an over-hemisection on the left at spinal T7-T8 vertebrae (T7-T8 cord). In this staggered-hemisection model, all direct descending supraspinal inputs, including 5-HT fibers, are cut, whereas spared local propriospinal neurons relay descending signals around the lesion site ( Fig. 5a and Supplementary Fig. 16 ) 15 . This procedure allows for some spontaneous recovery of voluntary locomotion (unlike in transected animals) in the absence of 5-HT. Bladders were expressed three times daily for at least 3 d, until bladder function recovered. Locomotion was evaluated 3-5 weeks after contusion or the second hemisection using parameters of plantar-foot placement, step frequency and iliac-crest height (hip).
In vitro preparation.
Under urethane anesthesia (1.8 g/kg, with a maximum dose of 0.45 g), the whole spinal cord caudal to the S2 injury level was removed from chronic spinal rats and immersed in oxygenated modified artificial cerebrospinal fluid (mACSF). For ventral-root recording and reflex testing, the sacral S4 and caudal Ca1 ventral roots and the Ca1 dorsal roots were used, and remaining roots removed. For imaging vessels in the cord, all roots were removed from the cord. After 0.5-1.5 h in mACSF (at 20 °C), the cord was transferred to a recording chamber containing normal ACSF (nACSF) saturated with carbogen (95% O 2 , 5% CO 2 ) and maintained near 21 °C, with a flow rate of 5 ml/min. In some cords, pO 2 was measured using the same sensor as was used in vivo (Optode), and the pO 2 was adjusted to a desired level (cord pO 2 : 10-50 mm Hg) by mixing small amounts of N 2 with the carbogen.
In vitro ventral-root-reflex recording and averaging. Dorsal and ventral roots were mounted on silver-silver chloride wires above the nACSF of the recording chamber and covered with a 5:1 mixture of petroleum jelly and mineral oil for monopolar stimulation and recording. The dorsal root was stimulated with a single pulse (0.1 ms, 0.02 mA, 3 × T (reflex threshold); repeated five times at 10-s intervals for one trial; trials repeated every 12 min), and the long-lasting reflex (LLR) response was recorded on the ventral roots, which corresponded to spasms in vivo, as previously described 15 . Ventral-root recordings were amplified (2,000×), high-pass filtered at 100 Hz, low-pass filtered at 3 kHz and recorded with a data-acquisition system sampling at 6.7 kHz (Axonscope 8, Axon Instruments, Burlingame, CA). We quantified the LLR with custom-written software (MATLAB, MathWorks, Natick, MA) by averaging the rectified ventral-root activity over a time-window of 500-4,000 ms after stimulus, an interval corresponding to in vivo muscle spasms 15 . Because of slow diffusion in whole spinal cord preparations, drug treatment required ten-fold higher concentrations of the drug than are used in thin-slice preparations, and peak effects required 10-15 min. To ensure selectivity of the drugs, we titrated them to a minimal dose that produced their peak effect, and results are reported at 10-45 min after drug application. Cumulative dose-response relations were computed by increasing drug doses at 12-min intervals (at doses of 0.003, 0.01, 0.03, 0.1 µM, down to 1 nM). The effects of drugs on the LLR were reversible on washout of the drug, but full recovery to baseline occurred only after several hours (data not shown), likely because of the large size of the whole-cord preparation. Thus, washout of drugs was not feasible between doses of the drugs used in the construction of their dose-response curves.
IR-DIC microscopy of vessels in vitro.
The sacrocaudal spinal cord was removed from rats, put in a recording chamber and imaged using an infrared differential-interference contrast (IR-DIC) microscope (Leica Axioskop2 FC Plus); the cord was maintained in nACSF, as described above in the section above. Spinal capillaries were imaged both in the dorsal horn of the whole sacrocaudal cord preparation (viewing through the dorsal surface, 200-300 µm below the pia), and throughout the cord in transverse sections or sagittal hemisected cords (0.5-mm transverse sections were cut on a vibratome; sagittal hemisection was performed by pulling the cord gently in half from rostral to caudal). Similar results were obtained for all methods of imaging spinal capillaries, and so the data acquired using all methods were combined. Spinal capillaries chosen for imaging were mostly in thin sacral S4 and coccygeal Co1 segments where light could readily traverse the tissue, with the following criteria for capillary identification: (i) they had a diameter of <11 µm; (ii) they were located deep under the pia and white-matter axons, ensuring that they were not pial vessels; (iii) they lacked continuous smooth-muscle coverage, as seen on arterioles; and (iv) they were wrapped with sparsely spaced, hemispherically shaped pericytes. We analyzed pericytes on straight stretches of capillaries 6 , where drug-induced constrictions were maximal, rather than at vessel branch points, which had pericytes that did not always constrict. Drug application was the same as for in vitro rootreflex recording methods. For normal uninjured rats, we applied tryptophan (n = 24 vessel preparations) and 5-HT (n = 7). For chronic spinal rats, we applied tryptophan (at three doses: 10, 30 and 100 µM; n = 6, 34 and 44, respectively), phenylalanine (n = 22), tyrosine (n = 20), 5-HTP (n = 23), tryptamine (n = 19), NSD1015 (with tryptamine or tryptophan; n = 16 each), GR127937 (with tryptamine or tryptophan, n = 10 and 21, respectively), zolmitriptan (at two doses, 3 and 300 nM; n = 8 and 10, respectively), RX821002 (with tyrosine, n = 5). Doses not provided here are quoted in the text or figure legends. Video was taken of vessels with an infrared camera and streamed to a computer through a high-definition video H.264 recorder (Blackmagic Design), and vessel diameter was computed offline at common focal planes, before and after drug-application effects reached steady state (5-10 min).
Spasms in awake chronic spinal rats.
Tail-muscle activity and spasms were evoked with brief electrical stimulation of the skin of the tail tip and recorded with tail-muscle EMG. Percutaneous EMG wires (50-µm stainless steel, Cooner Wires) were inserted into segmental tail muscles at the midpoint of the tail, and recordings were made while the rat was in a Plexiglas tube, as detailed previously 15 . Muscle spasms (long-lasting reflexes; LLR) were evoked with electrical stimulation of the skin at the distal tip of the tail (percutaneous stimulation; 0.2 ms, 10-mA pulse; 50-reflex threshold (50 × T); spasms evoked at 40-s intervals), and the tail was partly restrained from moving, by placing a piece of masking tape connecting the midpoint of the tail to a rigid stand. EMG was sampled at 5 kHz, rectified and averaged over a 500-ms to 4,000-ms interval to quantify spasms (LLR) using an Axoscope instrument (Axon Instruments) and MATLAB software (MathWorks). EMG over the period of 300 ms before stimulation was also averaged (background EMG). Drugs were dissolved in sterile saline and applied in vivo in chronic spinal rats by both i.p. and i.t. injections, and EMG was recorded both before and after drug injection. In other chronic spinal rats, the inhaled air was transiently switched to 95% oxygen (with 5% CO 2 ) for 60 s or to 10% CO 2 (in air for 30 s). Both gases were delivered into the Plexiglas tube holding the rat.
Spinal vascular imaging and blood flow in vivo.
To evaluate blood flow rate in capillaries, two-photon laser-scanning microscopy (TPLSM) was performed in vivo in chronic spinal rats 48 . Briefly, rats were anesthetized with urethane (1.8 g/kg, with a maximum dose of 0.45 g), and then a laminectomy was performed for T10-L4 vertebrae to expose the injured sacrocaudal spinal cord and the uninjured lumbar spinal cord. The exposed spinal segments were bathed in 0.9% saline, and the rat was positioned under the microscope with a stereotactic frame stabilizing the vertebrae. Fluorescein isocyanate dextran (FITC-dextran; 70,000 MW, Sigma-Aldrich) was injected into the lateral tail vein (0.3 ml, 5% (w/v) in saline), after warming the tail in water to dilate the vein. In vivo TPLSM was performed to track RBC velocity in capillaries (8-to 11-µm diameter), using a Leica SP5 MP TPLSM microscope and a Coherent Chameleon Vision II pulse laser tuned to 800 nm. Z-stacks and line scans through the first 200-400 µm of dorsal-horn spinal tissue were acquired through the spinal preparation using a 20× 1.0 N.A. water-dipping objective. RBC velocity measurements were made from line scans using Leica MM AF software, with a high frame rate adequate to accurately estimate velocity (~500 fps) 48 . Velocity was estimated before and after NSD1015 (dissolved in saline) was topically applied to the spinal cord. Velocity was measured in sections of the capillary between pericytes, chosen to be without obvious overall vessel-diameter changes, so that the velocity corresponds to the overall capillary flow rate (volume).
We also measured global blood flow rates, using dye-injection methods, in chronic spinal rats in the cord below the injury as compared to above the injury, and as compared to normal uninjured rats. Rats were anesthetized and laminectomy performed, as in the in vivo TPLSM experiments, to expose the lumbar and sacrocaudal spinal cord, which was filmed using a Panasonic G3 digital camera with a Leica macro-lens. Then, rats were perfused intracardially with the vital dye methylene blue (5% methylene blue solution, 1 g/ml, Sigma-Aldrich) in saline at room temperature using gravity-fed perfusion (at a height of 1.1 m to provide a common blood pressure close to normal; ~90 mm Hg). Global flow above and below the site of injury was estimated by the time taken for the methylene blue to turn major dorsal surface vessels blue (including the dorsal vein; the time at which the blue signal intensity quantitatively reached 90% of maximum steady-state value), thus ensuring that the dye had fully traversed spinal capillary beds and filled the venous return. Video images were processed in ImageJ. GR127935 (30 µM in saline absorbed into a 4-mm 3 piece of Gelfoam, Tocris) was applied locally onto the sacrocaudal spinal cord 5 min before perfusion (by putting the Gelfoam on the cord). For NO control experiments, rats were perfused for 2 min (through a pump) with ~100 ml of oxygenated nACSF containing the NO donor sodium nitrite (1 g/liter; Fisher) and heparin (300 IU/liter) to pre-dilate the vessels. Then the perfusion solution was switched to the 5% methylene-blue solution (gravity-fed), and the time taken for cord perfusion was again measured. We have previously noticed anecdotally that, after SCI, the cord caudal to the injury was perfused poorly during preparation for histology, and thus the above methylene-blue experiments were initially motivated by these observations. Because we found that sodium nitrite in oxygenated nACSF reversed this poor flow problem (see 'Results'), sodium nitrite in nACSF was injected into some rats before fixation to improve immunolabeling.
Oxygen concentration measurements in vivo.
Oxygen concentrations were measured in normal uninjured and SCI rats in vivo. Anesthesia (urethane), laminectomy and stereotactic stabilizing were similar to the setup for spinal vascular imaging, described above. The partial pressure of oxygen (pO 2 ) in the spinal cord was measured using an optical sensor 49 (Optode, MicroOptode; Unisense) with a 50-µm tip coated with a fluorophore that, when excited with 610-nm red light pulses, emitted 780-nm infrared light that varied in intensity proportionally to the concentration of nearby oxygen quenching this light (in which 1-µM O 2 = 0.62 mm Hg pO 2 ; calibrated with a VetStat blood-gas analyzer in serum, saline and nACSF). The sensor was mounted on a micromanipulator to advance the probe vertically to the dorsal cord surface. The probe either penetrated the pia and then penetrated deep into the gray matter of the dorsal and ventral horn, or dimpled the pia without penetrating it (by >200 µm) in the dorsal horn; similar pO 2 measurements were obtained with either method. The pia dimple method (as diagrammed in Fig. 3d ) caused less local damage and was thus preferred. Oxygen (pO 2 ) was measured in the cord caudal to the SCI (n = 52; sacral cord), and we compared this to values rostral to the SCI (n = 39; lumbar cord) and in uninjured rats at equivalent sacral and lumbar regions (n = 34 and 12, respectively). Drugs were dissolved in saline and applied topically onto the cord, in normal rats (GR127935, n = 7; RX821001, n = 15; NSD1015, n = 6) and in chronic spinal rats (GR127935, n = 8; RX821001, n = 14; NSD1015, n = 16). Arterial blood gases (from the carotid artery: pO 2 , pCO 2 , pH and hemoglobin oxygen saturation (Sat) were measured; VetStat, IDEXX), end-tidal CO 2 (CWE, CapStar-100) and respiration rate were monitored to ensure that they were in their normal ranges (95-105 mm Hg, 35-45 mm Hg, 7.3-7.4, 94-96%, 3.5-4.5% and 60-80 bps, respectively), and as necessary, were maintained with artificial respiration (using a trachea tube and respirator, CWE SAR1000). Under standard conditions, rats inhaled room air. As a control to test the sensitivity of the spinal cord pO 2 measures, rats briefly (for ~1 min) inhaled differing mixtures of O 2 and CO 2 , including: oxygen (100%, n = 7; hyperoxia; arterial blood gas pO 2 : 390 mm Hg, pCO 2 : 35 mm Hg; sat:100%), carbogen (95% O 2 , 5% CO 2 ; n = 20; blood gas pO 2 : ~350 mm Hg, pCO 2 : 50 mm Hg; sat: 100%), air with 10.5% O 2 (10.5% O 2 , 89.5% N 2 ; n = 7; hypoxic condition; blood gas pO 2 : 50 mm Hg, pCO 2 : 28 mm Hg; sat: 81%) or air with 10% CO 2 (n = 5; hypercapnia condition; blood gas pO 2 : 91 mm Hg, PCO 2 : 57 mm Hg; sat: 93%). Blood gases rapidly returned to normal (within 1-2 min) after these manipulations. There were also rapid proportional changes in spinal cord pO 2 as arterial pO 2 changed, although the spinal pO 2 showed sustained increases in pO 2 , outlasting the arterial changes (see 'Results'). Also, when the sacral spinal cord blood flow was acutely terminated at the end of the experiment (by transection), the spinal cord pO 2 dropped to zero within a few seconds. These inhaled gas and blood flow manipulations were used routinely to confirm the calibration and functioning of the pO 2 measurement device.
Locomotion analysis and i.t. drug injections.
Rats with high thoracic contusions or staggered hemisections were filmed with a high-speed digital camera (Panasonic, 120 frames/s) while walking across a 1.5-m-long Plexiglas runway with a mirror underneath, with markers on their hind limbs to estimate hip (iliac crest), knee, ankle and foot (fifth-metatarsal) position. The following parameters were used to evaluate locomotion: (i) weight support (height; hip height minus torso width, equivalent to torso clearance above the ground); (ii) leg-extensor spasms (quantified as the time that the foot overextends and drags, immobile, on its dorsal surface, relative to step-cycle duration); (iii) plantar steps (the number of plantar steps counted relative to the number of front steps); and (iv) foot placement in stance (measured as foot deviation behind the hip at onset of stance). Walking step-cycle cadence was defined by the front legs (front leg steps/sec) and was chosen to be similar before and after treatments with oxygen or GR127935. To allow them to inhale oxygen, rats were put into a chamber filled with 95% O 2 (carbogen, not pressurized) for 90 s. GR127935 was given i.t. (with one exception, given i.p. at 8 mg/kg). The i.t. injection was done under brief isoflurane anesthesia, as previously described 21 . That is, a standard 26-gauge injection needle (5/8 inch), connected to a Hamilton syringe, was inserted by sliding the needle down the caudal aspect of the L5 vertical process to a small opening between the L5 and L6 vertebrae (at cauda equina), obtained by lifting the hips 5-10 cm with one hand (rostral) while injecting with the other (caudal). Rats received isoflurane and a saline i.t. injection (30 µl) as a control, and 1 h later, a drug i.t. injection (GR127935, 10 mM, 30 µl, dissolved in sterile saline) in one experimental session. We quantified walking in control and drug-treated rats at ~5-30 min after the i.t. injection, long enough for the rat to be fully alert (rats awoke and walked in <2 min), but before washout of the i.t. injected drugs. A group of rats with contusions also received an i.t. injection of NSD1015 (100 mM in 30 µl), and its effects were determined at 1 h and 24 h after injection.
The BBB score is a qualitative 1-20 scoring system useful for studying the progression of locomotor recovery as rats go from having no walking ability acutely after injury to moderately improved walking ability in the chronic SCI state. However, in the chronic injured state of severely injured animals, as we studied, the BBB score is much less useful for detecting further improvements in locomotion, because the score saturates and is insensitive to improvements. Specifically, once rats can make occasional weight-supported plantar steps, they have a score of 10, and to go beyond 11, they need to coordinate the forelimb and hind limbs, which never happens after severe injury. Thus, in the chronic SCI state, rats remain at about a score of 11, regardless of treatment. Thus, we could not use this score.
Drugs and solutions.
Two kinds of ACSF were used for in vitro experiments: mACSF in the dissection dish before recording and nACSF in the recording
